[NP_P1] Poster Session 1

Sat. Oct 12, 2019 5:25 PM - 6:10 PM Poster Hall (Multi-purpose Hall)

座長：前原　俊介（持田製薬株式会社）

10月12日（土）　17:25～18:10　ポスター会場（福岡国際会議場 2階多目的ホール）
10月13日（日）　16:40～18:10　ポスター会場（福岡国際会議場 2階多目的ホール）

+Add all to schedule

5:25 PM - 5:30 PM

[NP-P1-1] Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on hyper-emotionality of olfactory bulbectomized rat.

^○Leo GOTOH^{1, 2}, Yuma OGUSHI², Takako KAWAGUCHI², Akihito HATANAKA², Kentaro KIRA², Hiroaki KAWASAKI^{1, 2} (1. Lab. of Neuroscience, Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 2. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan)

5:30 PM - 5:35 PM

[NP-P1-2] The expression pattern of FKBP5 protein in the amygdala of an animal model of depression

^○Hiroki SHIKANAI¹, Robel GHEBREAB², Takayuki YOSHIDA², Akitoyo HISHIMOTO³, Mitsuhiro YOSHIOKA², Takeshi IZUMI¹ (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Hokkaido, Japan, 2. Department of Neuropharmacology, Graduate School of Medicine, Hokkaido University, 3. Department of Psychiatry, Kobe University, Graduate School of Medicine)

5:35 PM - 5:40 PM

[NP-P1-3] Effects of fluvoxamine on depressive-like behaviors in adult rats experienced pharmacological stress during early postnatal period

^○Rumi SHINCHI, Yu ARAKI, Ryo FUKUMORI, taku YAMAGUCHI (Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki, Japan)

5:40 PM - 5:45 PM

[NP-P1-4] Antidepressant effects of resolvin D1 and resolvin D2 in chronic pain model mice

^○Hiroe SUZUKI, Natsuko HITORA-IMAMURA, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University)

5:45 PM - 5:50 PM

[NP-P1-5] Resilience of depression via regulation of acetylation of histone in the Bdnf gene in striatal Shati/Nat8l knockdown mice

^○Hajime MIYANISHI¹, Kyosuke UNO^{1, 2}, Shin-ichi MATSUMURA^{3, 4}, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, Toyama　unuversity, Toyama , 2. Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan, 3. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 4. Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)